Advertisement

Hospital pharmacy news, drug costs and specialty pharmacy trends

Becker’s reports on drug prices, shortages and the specialty pharmacy programs health systems are building. Coverage extends to 340B policy, pharmacy staffing and the distribution models.



More in Pharmacy

Becker’s asked pharmacy executives from hospitals and health systems, along with academic medical centers and universities across the U.S. to share their most innovative idea they’re bringing to their organization. The 20 executives featured in this article are all speaking…

CVS Health plans to open more pharmacies than it closes in 2026, signaling a shift after several years of store reductions, Bloomberg reported March 30. The company expects to open about 60 stores this year, including nearly 20 smaller, pharmacy-only…

Retail and e-commerce giants are rapidly expanding their presence in pharmacy services, prompting new concerns among hospital and health system leaders about losing ground in patient access and workforce recruitment. Amazon, for example, is significantly scaling its pharmacy footprint. The…

Novartis Pharmaceuticals Corp. has filed suit to block Washington state’s new 340B law, arguing it conflicts with federal 340B rules and violates the U.S. Constitution. The law, which takes effect June 10, 2026, bars drug manufacturers from restricting contract pharmacy…

Strategic Insights for the C-Suite Navigating Growth, Margin, & Enterprise Transformation Our 2026 Top Ten is here! This year, we’re offering health system executives a forward-looking lens on how pharmacy is evolving into one of the most powerful, underleveraged revenue…

Cigna’s Express Scripts continued its lead in the U.S. pharmacy benefit manager market for the second year in a row, processing nearly one-third of all prescription claims, according to a March 30 report from the Drug Channels Institute. The PBM…

The U.S.-Iran war is disrupting maritime trade and pushing oil prices above $100 a barrel, putting several medications at risk of shortage due to reliance on regional production and petrochemical inputs, according to a March 30 report from The Hill.…

When health system pharmacy margins tighten, the instinct is often to look for a big problem in purchasing performance or vendor management, such as: A bad contract.A major pricing shift.A vendor failure that clearly explains what went wrong. In reality,…

At many health systems, pharmacy leaders are often brought into infrastructure and operational planning after key decisions have already been made — a dynamic that can create downstream challenges for workflow, safety and efficiency. For Melissa Chase, PharmD, director of…

The FDA has approved Novo Nordisk’s Awiqli (insulin icodec-abae), making it the first once-weekly basal insulin available in the U.S. for adults with Type 2 diabetes. Awiqli is indicated as an adjunct to diet and exercise and is intended to…

Advertisement
Advertisement
Advertisement